molybdenum has been researched along with bathocuproine disulfonate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Prosser, RA; Yamada, Y | 1 |
| Cui, H; Geraghty, D; Guven, N; Liu, JJ; McKeage, MJ; Nott, LM; Zhang, AJ | 1 |
2 other study(ies) available for molybdenum and bathocuproine disulfonate
| Article | Year |
|---|---|
Copper chelation and exogenous copper affect circadian clock phase resetting in the suprachiasmatic nucleus in vitro.
Topics: Animals; Carbazoles; Chelating Agents; Circadian Clocks; Copper; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Glutamic Acid; In Vitro Techniques; Indole Alkaloids; Male; Mice; Mice, Inbred C57BL; Molybdenum; Phenanthrolines; Quinoxalines; Suprachiasmatic Nucleus; Valine | 2014 |
Copper transporter 1 in human colorectal cancer cell lines: Effects of endogenous and modified expression on oxaliplatin cytotoxicity.
Topics: Antineoplastic Agents; Cation Transport Proteins; Cell Line, Tumor; Chelating Agents; Copper; Copper Transporter 1; Copper-Transporting ATPases; Drug Synergism; Humans; Molybdenum; Organoplatinum Compounds; Oxaliplatin; Penicillamine; Phenanthrolines; Up-Regulation | 2017 |